These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25318546)

  • 1. Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease.
    Tang X; Holland D; Dale AM; Younes L; Miller MI
    J Alzheimers Dis; 2015; 44(2):599-611. PubMed ID: 25318546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease.
    Qiu A; Fennema-Notestine C; Dale AM; Miller MI;
    Neuroimage; 2009 Apr; 45(3):656-61. PubMed ID: 19280688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
    Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
    Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
    Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic Patterns of the Frontal-Subcortical Circuits in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Zhao H; Li X; Wu W; Li Z; Qian L; Li S; Zhang B; Xu Y
    PLoS One; 2015; 10(6):e0130017. PubMed ID: 26066658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease.
    Matsuoka T; Oya N; Yokota H; Akazawa K; Yamada K; Narumoto J;
    Psychiatry Clin Neurosci; 2020 Nov; 74(11):587-593. PubMed ID: 32609399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
    Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
    Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal manifold-regularized transfer learning for MCI conversion prediction.
    Cheng B; Liu M; Suk HI; Shen D; Zhang D;
    Brain Imaging Behav; 2015 Dec; 9(4):913-26. PubMed ID: 25702248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Sighinolfi G; Mitolo M; Pizzagalli F; Stanzani-Maserati M; Remondini D; Rochat MJ; Cantoni E; Venturi G; Vornetti G; Bartiromo F; Capellari S; Liguori R; Tonon C; Testa C; Lodi R
    J Alzheimers Dis; 2024; 99(1):177-190. PubMed ID: 38640154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.
    Kim GW; Kim BC; Park KS; Jeong GW
    Sci Rep; 2020 Jul; 10(1):10912. PubMed ID: 32616841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimal decisional space for the classification of Alzheimer's disease and mild cognitive impairment.
    Zhou Q; Goryawala M; Cabrerizo M; Wang J; Barker W; Loewenstein DA; Duara R; Adjouadi M
    IEEE Trans Biomed Eng; 2014 Aug; 61(8):2245-53. PubMed ID: 25051543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.